| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Precigen, Inc. (PGEN) has 13 insiders with recent SEC Form 4 filings, including 11 buys and 4 sells. PGEN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.77M | $20.45M | -119,250 | |
| Other | 755.5K | $4.10M | -29,131 | |
| Dir | 613.6K | $3.33M | - | |
| CFO | 554.5K | $3.01M | -41,884 | |
| COO | 497.8K | $2.70M | -42,703 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2016 | Hassan Fred | Director | Buy | 6,900 | $29.02 | $200,266.29 | New | |
| Aug 29, 2016 | Nimrodi Nir | Svp-corporate Development | Buy | 4,000 | $26.12 | $104,484.00 | New | |
| Jun 30, 2016 | Kirk Randal J | 10% Owner | Buy | 2,261,419 | $0.52 | $1,166,666.06 | +18.5% | |
| May 13, 2016 | Kirk Randal J | Chief Executive Officer | Buy | 41,830 | $23.92 | $1,000,573.60 | +0.6% | |
| Dec 11, 2015 | Kirk Randal J | Chief Executive Officer | Buy | 124,475 | $29.85 | $3,715,800.50 | +1.0% | |
| Dec 7, 2015 | Kirk Randal J | Chief Executive Officer | Buy | 237,525 | $30.69 | $7,289,642.25 | +3.8% | |
| Dec 4, 2015 | Krishnan Krish S46 | Chief Operating Officer | Sell | 20,900 | $35.66 | $745,370.97 | -19.8% | |
| Dec 4, 2015 | Krishnan Suma46 | Svp--product Development | Sell | 20,900 | $35.66 | $745,370.97 | -19.8% | |
| Sep 2, 2015 | Kirk Randal J | 10% Owner | Buy | 937,500 | $3.20 | $3,000,000.00 | +10.8% | |
| Jul 27, 2015 | Kirk Randal J | 10% Owner | Buy | 975,987 | $5.80 | $5,660,724.60 | +16.2% |